Aberrant methylation of the PTPRO gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients.
Aberrant methylation of the PTPRO gene in peripheral blood as a potential biomarker in esophageal squamous cell carcinoma patients.
复制标题
DOI:
10.1016/j.canlet.2011.08.032
复制
发表时间:
2012-02-28
期刊:
影响因子:
9.7
通讯作者:
Zhang, Hao
中科院分区:
文献类型:
--
作者:
You, Yan-Jie;Chen, Yu-Ping;Zheng, Xiao-Xuan;Meltzer, Stephen J.;Zhang, Hao
Inactivation of protein tyrosine phosphatase receptor-type O (PTPRO), a new member of the PTP family, by hypermethylation has been described in several forms of cancers. We evaluated PTPRO hypermethylation as a potential epigenetic biomarker in esophageal squamous cell carcinoma (ESCC). PTPRO hypermethylation was observed in 27 (75%) of 36 primary tumors and correlated significantly with depth of invasion (T-stage, P = 0.013). Among matched peripheral blood samples from ESCC patients, 13 (36.1%) of 36 had detectable methylated PTPRO in plasma, and 15 (41.7%) of 36 had it in the buffy coat. No methylated PTPRO was observed in normal peripheral blood samples from 10 healthy individuals. In addition, demethylation by 5-aza-dC treatment led to gene reactivation in PTPRO-methylated and -silenced ESCC cell lines. This is the first report for detection of PTPRO as a non-invasive biomarker for solid tumors in peripheral blood. Our findings suggest that hypermethylated PTPRO occurs frequently in ESCC. Its detection in the peripheral blood of ESCC patients illustrates its potential clinical application as an epigenetic biomarker for noninvasive diagnosis and disease monitoring.
登录
查看更多内容
影响因子:
2.9
作者:
Lee, TH;Montalvo, L;Busch, MP
通讯作者:
Busch, MP
影响因子:
4.8
作者:
Sun, Di;Zhang, Zhe;Hu, Lifu
通讯作者:
Hu, Lifu
影响因子:
254.7
作者:
Parkin, DM;Bray, F;Pisani, P
通讯作者:
Pisani, P
影响因子:
--
作者:
Ramaswamy, Bhuvaneswari;Majumder, Sarmila;Jacob, Samson T.
通讯作者:
Jacob, Samson T.
影响因子:
--
作者:
Hu, YC;Lam, KY;Srivastava, G
通讯作者:
Srivastava, G